To Evaluate the Efficacy and Safety of Minocycline Hydrochloride Foam in the Treatment of Moderate-to-severe Acne Vulgaris

PHASE3CompletedINTERVENTIONAL
Enrollment

372

Participants

Timeline

Start Date

September 17, 2021

Primary Completion Date

September 27, 2022

Study Completion Date

October 14, 2022

Conditions
Acne Vulgaris
Interventions
DRUG

FMX101

topically once daily

Trial Locations (29)

100029

China-Japan Friendship Hospital, Beijin

100050

Beijing Friendship Hospital, Capital Medical University, Beijing

100053

Xuanwu Hospital Capital Medical University, Beijing

100144

Peking University Shougang Hospital, Beijing

100191

Peking University Third Hospital, Beijing

102218

Beijing Tsinghua Changgung Hospital, Beijin

110001

The First Hosptial of China Medical University, Shenyang

110004

Shengjin Hospital of China Medical University, Shenyang

130061

The First Bethune Hosptial of Jilin University, Changchun

200040

Shanghai Medical College of Fudan University, Shanghai

200050

Shanghai Skin Disease Hospital Skin Disease Hospital of Tongji University, Shanghai

210042

Institute of Dermatology Chinese Academy of Medical Sciences, Nanjin

214023

Wuxi People's Hospital, Wuxi

250063

Qilu Hospital of Shandong University, Jinan

266003

The Affiliated Hosptial of Qingdao University, Qingdao

300052

Tianjin Medical University General Hospital, Tianjin

300120

Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital, Tianjing

310009

Hangzhou Third People's Hospital, Hangzhou

310020

Sir Run Run Shaw Hospital of Zhejiang University School of Medicine, Hangzhou

400038

The Southwest Hospital Of Amu, Chongqing

400042

The First Affiliated Hospital Of Chongqing Medical University, Chongqing

410013

The Third Xiangya Hospital Of Central South University, Changsha

510091

Dermatology Hosptial of Southern Medical University, Yuexiu

510120

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou

510260

The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou

610044

West China Hospital Sichuan University, Chengdu

710004

The Second Affiliated Hospital of Xi'an Jiaotong University, Xi’an

050004

The Second Hospital Of Hebei Medical University, Shijiazhuang

Unknown

The Second Affiliated Hosptial Zhejiang University School Of Medicine, Hangzhou

All Listed Sponsors
lead

Cutia Therapeutics (Shanghai) Co., Ltd

INDUSTRY

NCT04960930 - To Evaluate the Efficacy and Safety of Minocycline Hydrochloride Foam in the Treatment of Moderate-to-severe Acne Vulgaris | Biotech Hunter | Biotech Hunter